AVECTAS.COM: Keyword Density Checker

Total words: 1403 | 2-word phrases: 371 | 3-word phrases: 399 | 4-word phrases: 409

PAGE INFO

Title	Try to keep the title under 60 characters (37 characters) Avectas - Cell Engineering Technology
Description	Try to keep the meta description between 50 - 160 characters (162 characters) Avectas is a cell engineering technology business focused on improving the cost, manufacturing and patient outcomes for the next generation of cellular therapies.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (10 characters) Solupore®

#	Keyword	Frequency	Density
1	cellgene meeting on	3	0.75%
2	meeting on the	2	0.50%
3	outcomes and we	2	0.50%
4	complex editing and	2	0.50%
5	of cell therapies	2	0.50%
6	generation of cell	2	0.50%
7	next generation of	2	0.50%
8	the next generation	2	0.50%
9	challenging cargo delivery	2	0.50%
10	our technology solupore	2	0.50%
11	2024 hamburg germany	2	0.50%
12	partnerships are essential	2	0.50%
13	nonviral delivery platform	2	0.50%
14	essential to ensure	2	0.50%
15	these lifesaving gene	2	0.50%
16	patient outcomes and	2	0.50%
17	are essential to	2	0.50%
18	and we are	2	0.50%
19	to engage with	2	0.50%
20	researchers who are	2	0.50%
21	we are actively	2	0.50%
22	developing these lifesaving	2	0.50%
23	who are developing	2	0.50%
24	and researchers who	2	0.50%
25	seeking to engage	2	0.50%
26	actively seeking to	2	0.50%
27	are actively seeking	2	0.50%
28	are developing these	2	0.50%
29	mesa cellgene meeting	1	0.25%
30	mesa october 7	1	0.25%

#	Keyword	Frequency	Density
1	who are developing these	2	0.49%
2	patient outcomes and we	2	0.49%
3	are developing these lifesaving	2	0.49%
4	seeking to engage with	2	0.49%
5	cellgene meeting on the	2	0.49%
6	actively seeking to engage	2	0.49%
7	are actively seeking to	2	0.49%
8	we are actively seeking	2	0.49%
9	and we are actively	2	0.49%
10	outcomes and we are	2	0.49%
11	and researchers who are	2	0.49%
12	developing these lifesaving gene	2	0.49%
13	the next generation of	2	0.49%
14	next generation of cell	2	0.49%
15	generation of cell therapies	2	0.49%
16	are essential to ensure	2	0.49%
17	partnerships are essential to	2	0.49%
18	researchers who are developing	2	0.49%
19	commercialization partner access to	1	0.24%
20	box commercialization partner access	1	0.24%
21	technology get in touch	1	0.24%
22	of regulatory fillings check	1	0.24%
23	partner access to technology	1	0.24%
24	access to technology under	1	0.24%
25	to technology under codevelopment	1	0.24%
26	documentation of regulatory fillings	1	0.24%
27	to main content avectas	1	0.24%
28	skip to main content	1	0.24%
29	by appropriate documentation of	1	0.24%
30	avectas and our cell	1	0.24%
31	2024 hamburg germany isscr	1	0.24%
32	isscr 2024 hamburg germany	1	0.24%
33	events isscr 2024 hamburg	1	0.24%
34	upcoming events isscr 2024	1	0.24%
35	avectas upcoming events isscr	1	0.24%
36	at avectas upcoming events	1	0.24%
37	events at avectas upcoming	1	0.24%
38	upcoming events at avectas	1	0.24%
39	and our cell engineering	1	0.24%
40	engineering technology get in	1	0.24%

#	URL	Whois	Check
1	https://www.linkedin.com/company/avectas/	Whois	linkedin.com
2	https://twitter.com/avectas	Whois	twitter.com